Novo Nordisk's Magic Run Continues Even With Increasing Competition
https://www.fool.com/investing/2024/02/12/novo-nordisks-magic-run-continues-even-with/?source=iedfolrf0000001
Feb 12, 2024 - Novo Nordisk's Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
0
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190
Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.
0
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001
Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs.
0
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
0
3 Reasons Growth Investors Will Love Novo Nordisk (NVO)
https://www.zacks.com/stock/news/2220495/3-reasons-growth-investors-will-love-novo-nordisk-nvo?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2220495
Feb 02, 2024 - Novo Nordisk (NVO) could produce exceptional returns because of its solid growth attributes.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0
Sanofi (SNY) Misses on Q4 Earnings and Sales, Stock Down
https://www.zacks.com/stock/news/2219619/sanofi-sny-misses-on-q4-earnings-and-sales-stock-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2219619
Feb 01, 2024 - Sanofi (SNY) misses fourth-quarter estimates for earnings and sales. It maintains 2024 earnings growth guidance.
0
Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/31/novo-nordisk-nvo-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Jan 31, 2024 - NVO earnings call for the period ending December 31, 2023.
0
ADP Cools to 107K Private-Sector Jobs; BA, NVO Beat in Q4
https://www.zacks.com/stock/news/2218851/adp-cools-to-107k-private-sector-jobs-ba-nvo-beat-in-q4?cid=CS-ZC-FT-ahead_of_wall_street-2218851
Jan 31, 2024 - We've now spent a full six months sub-200K private-sector job gains per month.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2218712/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2218712
Jan 31, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0